HHMI
NUVA

Howard Hughes Medical Institute’s NuVasive, Inc. NUVA Stock Holding History

Howard Hughes Medical Institute’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,066
Closed -$159K – 132
2017
Q2 		$159K Buy
2,066
+936
+83% +$70K 0.03% 128
2017
Q1 		$84K Buy
+1,130
New +$82K 0.02% 139

Other funds holding NUVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

Howard Hughes Medical Institute's NUVA Position: Q3 2017 in Review

Howard Hughes Medical Institute sold out of NuVasive, Inc. (NUVA) in Q3 2017, closing a stake of 2,066 shares — an estimated $159K sold.

Howard Hughes Medical Institute first reported a position in NUVA in Q1 2017 and held it in 2 quarters. The position peaked at $159K in Q2 2017. 263 funds tracked by Wall St. Rank hold NUVA as of Q3 2017.

  • Howard Hughes Medical Institute reported no remaining NuVasive, Inc. position as of Q3 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 2,066 NuVasive, Inc. shares in Q3 2017, an estimated $159K.
  • Howard Hughes Medical Institute first reported a position in NuVasive, Inc. in Q1 2017 and held it in 2 quarters.
  • Howard Hughes Medical Institute's NuVasive, Inc. position peaked at $159K in Q2 2017.
  • 263 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2017, filed 2 Nov 2017.